One Prescription, Six Years: What Is Not Being Measured in the Ruti Aga Case

In my ledger, beside the 2026 Tokyo Marathon, there is a name — Ruti Aga. Three lines below it, all marked 'second': three World Marathon Major runner-up finishes. After she won a half marathon in China in March, the sample collected showed methylprednisolone. The ban runs from 10 September, six years. The new column I now have to open in the ledger will not hold a time; it will hold an annulment. The first results sheet is never just paper; it is a doorway. In this case the door opened the wrong way — not from the athlete toward the tester, but from a prescription slip toward a six-year decision. When I held my first results sheet at the National Stadium in Dhaka in 2026, it was a carbon copy with hand-written times and not a trace of electronic timing. That week built a habit: I do not measure a career by one headline, I keep the whole column beside it. Aga's column reads one Major win (Tokyo, 2026) and three Major runner-up finishes — globally a top fifteen-to-twenty-five record, consistent and podium-capable, but never the athlete the event was built around. That tier is the most crowded layer of the Ethiopian highland marathon pipeline, and the least protected. Methylprednisolone is no power steroid; it is a glucocorticoid used to reduce inflammation. A knee complaint sending a marathoner toward that drug class is unremarkable. Under WADA rules glucocorticoids are prohibited only in-competition, by injection, oral or rectal route. Out of competition, with proper documentation and clearance, the treatment is legal. The problem sits in timing and paperwork. The 'doctor' at the centre of the case is a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace that the clinic flatly denied. The sanction arithmetic is not simple: the tampering component is four years, and with the underlying violation the total reaches six. The clock started on 10 September, when she was 32. Road racing has a defined risk zone, and Aga sat in it. The March half marathon was a label-level race — appearance-fee driven, outside the routine camera and testing footprint of the Diamond League circuit. There, testing reach is set by the local anti-doping organisation plus targeted Athletics Integrity Unit sampling, not by the race's commercial profile. High fee, low surveillance: the most exposed junction for a mid-tier elite. I have said it often — the question is never only who won, it is who feeds the pipeline. Here too: who paid for the sample collection, who decided who would be tested. The number that matters here is not a time but an annulment. Because the sample came at the March half marathon, that result goes: title, prize money, ranking points. The 2026 Tokyo title survives this decision. Her greatest achievement stands; her most recent earnings are erased. For the organiser it is an awkward document too — an international label race lost its champion's result, and the race's own name will not even appear in most records. The medical support structure is the decisive signal. The Ethiopian highland pipeline — Addis Ababa, Sululta, Asella — typically pairs a personal coach with an agent-managed calendar. A licensed team physician who understands Therapeutic Use Exemption paperwork is a luxury, not a guarantee. So medical questions fall into informal channels: family, acquaintances, old contacts. That is exactly what happened here. Intent is secondary. The larger question is who was supposed to secure the legal paperwork. Timing teaches the lesson. Glucocorticoids are prohibited only in-competition. Administered before the race, documented, the treatment is entirely legal. Present in an in-competition sample, the story leaves the therapeutic room. Aga's explanation involves knee pain — credible for a marathoner, since chronic patellofemoral loading is standard in the event. But when fabricated documents sit beside a credible explanation, the weight of punishment shifts from the drug to the paper. What is absent from the record also matters. No race name, no winning time, no sample type, no year of decision. Those four gaps hobble the researcher. Without a time the mark cannot be positioned globally; without course profile, altitude and women-only versus mixed pacing cannot be assessed; and the 2026-2026 marks sit inside the first carbon-plate generation, so a naive comparison to career bests misleads. This is a measurement question, not a doping question. The age arithmetic is brutal. Six years at 32 means a return at roughly 38. The marathon's extended peak window, 27 to 33 with outliers past 35, technically allows late racing. But six years outside competition and testing means isolation from the elite training system, the agent network and the invitation circuit. A return to World Marathon Major level is highly improbable. The economics need measuring too. One Major win and three Major runner-up finishes put her in the band where income comes from appearance fees and podium bonuses rather than global endorsements. For an athlete an event is built around, a ban is marginal; for one who sells tickets race by race, it is close to total. Aga is in the second group, and the damage is near-total, not borderline. A counter-question is due. Six years looks like a hard message. Steelman the institution: what the Athletics Integrity Unit can adjudicate is documents. It cannot adjudicate the medical reality of athletics. But the question lingers elsewhere. In the road-race economy a mid-tier elite marathoner is effectively a self-employed contractor — no team doctor, no TUE literacy, no legal support, yet the entire documentary burden is hers alone. The sanction punished an individual paperwork failure; the vacuum that produced the paper was left intact. The message lands in two layers: 'do not lie', which is necessary, and 'tampering is punished harder than the substance', which is not a comfortable message for any regulatory system. Looking forward, the question is institutional, not personal. Over the next decade, whose door will the first knee question knock on for the women and men rising from the Ethiopian highlands? The coach, the agent, or the family doctor with no registration? In the mixed zone the medal meets the microphone, and meets the only person nobody asked where the paper came from. A stopwatch can start a career, but a ledger decides what it meant. Ruti Aga's ledger will read six years — and the column beside it stays blank, because nobody kept her medical file in that room.